BURLINGTON – Life science giant LabCorp is rolling out a suite of services to help companies bring employees back to work as the COVID-19 pandemic drags on as well as an additional COVID-19 related test.
The return to work service includes:
- Employee check-in health questionnaires
- Temperature screens
- COVID-19 test collection either at the job site or offsite
- Employee access to LabCorp’s COVID-19 testing, including the recently announced at-home kit and a new fingerstick antibody blood test
- Later this fall, flu vacination servives
Adam Schechter, chief executive officer at LabCorp, tipped on today’s new program news in an interview with CNBC on Wednesday. Schechter also said that the current capacity for COVID-19 testing is sufficient to support a reopening of the US economy.
Current COVID-19 testing capacity can support reopening of economy, says LabCorp CEO
“We have been helping keep people safe and healthy for 50 years and are uniquely positioned to assist employers in their return to work strategies,” Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, said in Thursday;s announcement.
“Through science and research, LabCorp’s diagnostic testing capabilities set the industry standard in quality and accuracy. Employer Services is another example of our commitment to being an integral part of the solution to this health crisis.”
The new service is not entirely new. Previously known as Wellness Corporate Solutions, LabCorp Employer Services offers “comprehensive wellness solutions, including biometric screening, occupational testing, and diagnostic services,” the company said.
LabCorp launches fingerstick blood test for COVID-19 antibodies
LabCorp says the new test “detects IgG antibodies to the virus that causes COVID-19 and provides highly specific results equivalent to LabCorp’s other antibody blood testing methods.”
The test uses the EUROIMMUN test developed in Germany which received Emergency Use Authorization by the U.S. Food and Drug Administration.
“LabCorp completed independent validation studies on this testing,” the company said.
“The COVID-19 IgG antibody blood test detects the presence of antibodies to the virus and can help determine if an individual may have been exposed to the virus. While antibody tests are helpful to understand if an individual has developed antibodies and a potential immune response, antibody testing should not be used as the sole basis to diagnose or exclude infection.”
Read more about the return-to-work service and the additional test at this site.
